The big plus with this drug is the pain relief and there’s no restriction on how long a patient can use the drug. Most common side effect is diarrhea the side effect for treating constipation, nothing new there. The drug will go on sale in the 4th quarter. BD
Ironwood Pharmaceuticals Inc. (IRWD) and Forest Laboratories Inc. (FRX) won U.S. regulatory approval of their linaclotide treatment for irritable bowel syndrome with constipation.
The therapy was also approved for chronic constipation, the Food and Drug Administration said today in a statement. As many as 11 million Americans have irritable bowel syndrome with constipation, a disorder that causes abdominal pain, according to Cambridge, Massachusetts-based Ironwood.